Technology | Cardiac Resynchronization Therapy Devices (CRT) | March 23, 2017

Biotronik Launches Edora Series Pacemakers and Quadripolar CRT-Ps

The company’s smallest, lightest devices feature MRI AutoDetect, Biotronik Home Monitoring and physiological rate adaptation for enhanced patient care

Biotronik, Edora series, pacemakers, CRT-Ps

March 23, 2017 — Biotronik announced the European launch of the Edora series, its smallest series of pacemakers and cardiac resynchronization therapy pacemakers (CRT-Ps). The new devices are equipped with features geared towards improving patient safety, therapy and comfort. Moreover, Edora pacemakers are significantly smaller and lighter than preceding models, achieving compactness and full functionality without compromising battery life.

“Biotronik’s new series of pacemakers fits well in the current age of smart technologies, with devices that are smaller, lighter and shorter while retaining longevity,” stated Saravanan AL Krishinan, M.D., Hospital Sultanah Bahiyah, Alor Setar, Malaysia. "What's more, the devices offer simplified MRI [magnetic resonance imaging] access, which is often crucial for better patient care.”

To facilitate patient access to MRI, Edora pacemakers and CRT-Ps are MR-conditional and feature Biotronik’s MRI AutoDetect functionality. This means that within a programmable window of up to 14 days, the device’s built-in sensor can detect an MRI environment and automatically switch the system to MRI mode; the device then automatically switch back to its standard mode once the scan is complete. Since the device is only in MRI mode for the duration of the scan, the patient receives optimal therapy for the maximum amount of time.

Devices in the Edora series also support Biotronik Home Monitoring for remote long-term patient care with a streamlined workflow. Biotronik Home Monitoring automatically collects cardiovascular data from the patient’s device on a daily basis and transmits it remotely to the physician without the need for any patient interaction. This facilitates the early detection of arrhythmias, with clinical trial results demonstrating that the monitoring system significantly reduces hospitalization for atrial arrhythmia and related stroke in pacemaker patients.

Edora CRT-Ps are specifically tailored for individualized therapy through quadripolar technology for flexible pacing in the left ventricle (LV). This is complemented by a comprehensive LV lead portfolio, which caters for diverse patient anatomies.

This product is currently only approved for use in the European Economic Area. The company expects to announce FDA approval in the second quarter of 2017. 

For more information: www.biotronik.com

Related Content

Medtronic AdaptivCRT Feature Associated with Improved Heart Failure Patient Survival
News | Cardiac Resynchronization Therapy Devices (CRT) | May 22, 2018
Medtronic plc announced study results showing its AdaptivCRT algorithm is associated with improved patient survival....
Medtronic Recalls CRT-Ds and ICDs Due to Manufacturing Error Preventing Electrical Shock Delivery
News | Cardiac Resynchronization Therapy Devices (CRT) | February 26, 2018
The U.S. Food and Drug Administration (FDA) announced that Medtronic is recalling certain implantable cardioverter...
Abbott Announces MR-Conditional Labeling for Quadra Assura CRT-D and Fortify Assura ICD
Technology | Cardiac Resynchronization Therapy Devices (CRT) | January 03, 2018
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT) | August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT) | July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Videos | Cardiac Resynchronization Therapy Devices (CRT) | May 23, 2017
This video, provided by ERB, demonstrates the function and implantation of the WiSE CRT (Wireless Stimulation Endocar
Biotronik Announces FDA Approval of MultiPole Pacing
Technology | Cardiac Resynchronization Therapy Devices (CRT) | May 11, 2017
May 11, 2017 — Biotronik announced U.S.
Biotronik Launches First FDA-Approved CRM Devices with MRI AutoDetect Technology
Technology | Cardiac Resynchronization Therapy Devices (CRT) | May 10, 2017
Biotronik announced the availability of the first U.S. Food and Drug Administration (FDA)-approved cardiac rhythm...
Overlay Init